Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2025-12-24 @ 5:10 PM
NCT ID:
NCT01260350
Eligibility Criteria:
Inclusion Criteria:
* Chronic Genotype 2 or 3 HCV-infection or Genotype 1, serum HCV RNA ≥ 50,000 IU/mL
* Not co-infected with HIV
* Use of highly effective contraception methods if female of childbearing potential or sexually active male
Exclusion Criteria:
* History of any other clinically significant chronic liver disease
* Pregnant or nursing female or male with pregnant female partner
* History of significant drug allergy to nucleoside/nucleotide analogs.
* Participation in a clinical study within 3 months prior to first dose
* Positive result for significant drug use at Screening
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01260350
Study Brief:
Protocol Section:
NCT01260350